百济神州聘任汪来担任总裁、全球研发负责人

Core Viewpoint - BeiGene has appointed Wang Lai as the new President and Global Head of R&D, effective from December 17, following the approval of the board of directors [1] Group 1: Appointment Details - Wang Lai has been with BeiGene since 2011 and has held multiple leadership roles in R&D, with responsibilities expanding over time [1] - Prior to joining BeiGene, Wang served as the Head of Research at Joyant Pharmaceuticals in Dallas, Texas from 2008 to 2011 [1] - Wang holds a Bachelor of Science degree from Fudan University (1996) and a PhD from the University of Texas Health Science Center at San Antonio (2001) [1] Group 2: Responsibilities - As President and Global Head of R&D, Wang will oversee the management of R&D, business development, and alliance management functions [1]